Skip to main content

Bod Australia Consumer Discretionary

$0.270 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
18 May 2025 at 9:04am
Register to track BDA and receive email alerts.
Subject
MediaBot
BDA Article: Bod Australia, Alicanto Minerals chase equity injections

StockBot
BDA Ann: Change of ASX code to BOD

StockBot
BDA Ann: BOD to conduct Schedule 3 clinical trial of new CBD product

StockBot
BDA Ann: Change in substantial holding

StockBot
BDA Ann: Investor Presentation

StockBot
BDA Ann: Record revenue achieved during FY2021

StockBot
BDA Ann: Appendix 4E and Full Year Statutory Accounts

StockBot
BDA Ann: Appointment of leading executive as Chief Financial Officer

StockBot
BDA Ann: Final Director's Interest Notice

StockBot
BDA Ann: Initial Director's Interest Notice - Hanno Cappon

StockBot
BDA Ann: Non-Executive Director resignation and appointment

StockBot
BDA Ann: Quarterly Activities Report and Appendix 4C

StockBot
BDA Ann: 212% increase in medicinal cannabis product sales in FY2021

StockBot
BDA Ann: Bod broadens UK sales footprint

StockBot
BDA Ann: Results of Meeting

StockBot
BDA Ann: Launch of new medicinal cannabis product and UK update

StockBot
BDA Ann: Highest ever monthly sales of medicinal cannabis products

StockBot
BDA Ann: Notice of Extraordinary General Meeting/Proxy Form

StockBot
BDA Ann: Quarterly acitivities report and Appendix 4C

StockBot
BDA Ann: Appointment of leading executive as Chief Financial Officer

StockBot
BDA Ann: Bod secures first binding purchase order for US market

StockBot
BDA Ann: Record medicinal cannabis sales achieved during Q3 FY2021

StockBot
BDA Ann: Collaboration agreement with Drug Science for long-COVID

StockBot
BDA Ann: Strong half driven by international expansion

StockBot
BDA Ann: Half Year Accounts and Appendix 4D

StockBot
BDA Ann: Amendment to 30 June 2020 financial statements

StockBot
BDA Ann: Resignation of Chief Financial Officer

StockBot
BDA Ann: Quarterly Activities Report and Appendix 4C

StockBot
BDA Ann: Bod delivers record attributable sales in Q2 FY2021

StockBot
BDA Ann: Bod achieves strong second half medicinal cannabis sales

StockBot
BDA Ann: Change of Director Interest Notices - J Patterson and A Bedi

StockBot
BDA Ann: Appendix 3G

StockBot
BDA Ann: Section 708A cleansing notice

StockBot
BDA Ann: $871,413 in binding orders secured for the Italian market

StockBot
BDA Ann: Appendix 2A

StockBot
BDA Ann: Medical advisory board formed to capitalise on TGA decision

StockBot
BDA Ann: Proposed issue of Securities - BDA

StockBot
BDA Ann: Bod secures commitments to raise $8m via private placement

StockBot
BDA Ann: Trading Halt

StockBot
BDA Ann: Bod to benefit from US push to decriminalise cannabis

StockBot
BDA Ann: Bod to benefit from UN decision to reclassify cannabis

StockBot
BDA Ann: Bod broadens European footprint with binding purchase order

StockBot
BDA Ann: Results of Annual General Meeting

StockBot
BDA Ann: CEO Presentation to Annual General Meeting

StockBot
BDA Ann: $1m binding purchase order received for Italian market entry

StockBot
BDA Ann: Strong growth in medicinal cannabis sales continues

StockBot
BDA Ann: Appendix 4G and Corporate Governance Statement

StockBot
BDA Ann: Annual Report to shareholders

StockBot
BDA Ann: Notice of Annual General Meeting and Proxy Form

StockBot
BDA Ann: Bod launches CBD products in the Netherlands

Register to track BDA and receive email alerts.

Similar Companies

Bapcor
BAP
Delecta
DLC
Funtastic
FUN
Jatcorp
JAT
National Tyre & Wheel
NTD
Supply Network
SNL
TTA Holdings
TTA